Dynamics of neurological soft signs and its relationship to clinical course in patients with first-episode schizophrenia

Psychiatry Research

Volumn 200, Issue 2-3, 2012, Pages 67-72

  Prikryl, Radovan ^a,b   Ceskova, Eva ^a,b   Tronerova, Silva ^b   Kasparek, Tomas ^a,b   Kucerova, Hana Prikrylova ^a,b   Ustohal, Libor ^a,b   Venclikova, Simona ^b   Vrzalova, Michaela ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Clinical course; First episode schizophrenia; Follow up; NES; Neurological Evaluation Scale; Neurological soft signs; NSS

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; NEUROLOGIC EXAMINATION; NEUROLOGICAL SOFT SIGN; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SENSORIMOTOR INTEGRATION; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; HUMANS; MALE; NEUROLOGIC EXAMINATION; SCHIZOPHRENIA;

EID: 84872378672     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.03.008     Document Type: Article

References (55)

1. Addington J., Addington R. Outcome after discharge from an early psychosis program. Schizophrenia Research 2008, 106:363-366.
2. Andreasen N.C., O'Leary D.S., Cizadlo T. Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:9985-9990.
3. Andreasen N.C., Carpenter W.T., Kane J.M., Lasse R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 2005, 162:441-449.
4. Arango C., Kirkpatrick B., Buchanan R.W. Neurological signs and the heterogeneity of schizophrenia. American Journal of Psychiatry 2000, 157:560-565.
5. Bachmann S., Bottmer C., Schröder J. Neurological soft signs in first-episode schizophrenia: a follow-up study. American Journal of Psychiatry 2005, 162:2337-2343.
6. Bersani G., Gherardelli S., Clemente R., Di Giannantonio M., Grilli A., Conti C.M. Neurologic soft signs in schizophrenic patients treated with conventional and atypical antipsychotics. Journal of Clinical Psychopharmacology 2005, 25:372-375.
7. Biswas P., Malhotra S., Malhotra A., Gupta N. Comparative study of neurological soft signs in schizophrenia with onset in childhood, adolescence and adulthood. Acta Psychiatrica Scandinavica 2007, 115:295-303.
8. Boks M.P., Selten J.P., Leask S., Van den Bosch R.J. The 2-year stability of neurological soft signs after a first episode of non-affective psychosis. European Psychiatry 2006, 21:288-290.
9. Bollini A.M., Compton M.T., Esterberg M.L., Rutland J., Chien V.H., Walker E.F. Associations between schizotypal features and indicators of neurological and morphological abnormalities. Schizophrenia Research 2007, 92:32-40.
10. Bombin I., Arango C., Buchanan R.W. Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophrenia Bulletin 2005, 31:962-977.
11. Buchanan R.W., Heinrichs D.W. The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs of schizophrenia. Psychiatry Research 1989, 27:335-350.
12. Chan R.C.K., Xu T., Heinrichs R.W., Yu Y., Wang Y. Neurological Soft Signs in Schizophrenia: a meta-analysis. Schizophrenia Bulletin 2009, 36:1089-1104.
13. Chen E.Y., Kwok C.L., Au J.W., Chen R.Y., Lau B.S. Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatrica Scandinavica 2000, 102:342-349.
14. Chen E.Y.H., Chan R.C.K. The Cambridge Neurological Inventory: clinical, demographic, and ethnic correlates. Psychiatric Annals 2003, 33:202-210.
15. Chen E.Y., Hui C.L., Chan R.C., Dunn E.L., Miao M.Y., Yeung W.S. A 3-year prospective study of neurological soft signs in first-episode schizophrenia. Schizophrenia Research 2005, 75:45-54.
16. Compton M.T., Bollini A.M., McKenzie Mack L., Kryda A.D., Rutland J., Weiss P.S. Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls. Schizophrenia Research 2007, 94:64-73.
17. Cuesta M.J., Peralta V., Juan J.A. Abnormal subjective experiences in schizophrenia: its relationships with neuropsychological disturbances and frontal signs. European Archives of Psychiatry and Clinical Neuroscience 1996, 246:101-105.
18. Dazzan P., Morgan K.D., Orr K.G., Hutchinson G., Chitnis X., Suckling J., Fearon P., Salvo J., McGuire P.K., Mallett R.M., Jones P.B., Leff J., Murray R.M. The structural brain correlates of neurological soft signs in ÆSOP first-episode psychoses study. Brain 2004, 127:143-153.
19. Emsley R., Turner H.J., Oosthuizen P.P., Carr J. Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophrenia Research 2005, 75:35-44.
20. Flyckt L., Sydow O., Bjerkenstedt L., Edman G., Rydin E., Wiesel F.A. Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Research 1999, 86:113-129.
21. Gupta S., Andreasen N.C., Arndt S., Flaum M., Schultz S.K., Hubbard W.C. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. American Journal of Psychiatry 1995, 152:191-196.
22. Heinrichs D.W., Buchanan R.W. Significance and meaning of neurological signs in schizophrenia. American Journal of Psychiatry 1988, 145:11-18.
23. Hui C.L.M., Wong G.H.Y., Chiu C.P.Y. Potential endophenotype for schizophrenia: Neurological Soft Signs. Annals, Academy of Medicine, Singapore 2009, 38:408-413.
24. International Statistical Classification of Diseases and Related Health Problems Revision 1989, World Health Organization, Geneva.
25. Jahn T., Hubmann W., Karr M., Mohr F., Schlenker R., Heidenreich T. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses. Psychiatry Research 2006, 142:191-199.
26. John J.P., Arunachalam V., Ratnam B., Isaac M.K. Expanding the schizophrenia phenotype: a composite evaluation of neurodevelopmental markers. Comprehensive Psychiatry 2008, 49:78-86.
27. Kay S., Fiszbein A., Opler L.A. The positive and negative syndrome scale for schizophrenia. Schizophrenia Bulletin 1987, 13:261-278.
28. Keshavan M.S., Sanders R.D., Sweeney J.A., Diwadkar V.A., Goldstein G., Pettegrew J.W., Schooler N.R. Diagnostic specifity and neuroanatomical validity of neurological abnormalities in first episode psychoses. American Journal of Psychiatry 2003, 160:1298-1304.
29. Madsen A.L., Vorstrup S., Rubin P., Larsen J.K., Hemmingsen R. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatrica Scandinavica 1999, 100:119-125.
30. Malla A.K., Norman R.M., Aguilar O., Cortese L. Relationship between neurological 'soft signs' and syndromes of schizophrenia. Acta Psychiatrica Scandinavica 1997, 96:274-280.
31. Mayoral M., Bombin I., Zabala A., Robles O., Moreno D., Parellada M. Neurological soft signs in adolescents with first episode psychosis: two-year follow up. Psychiatry Research 2008, 161:344-348.
32. Meehl P.E. Schizotaxia revisited. Archives of General Psychiatry 1989, 46:935-944.
33. Mittal V.A., Neumann C., Saczawa M., Walker E.F. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Archives of General Psychiatry 2008, 65:165-171.
34. Mohr F., Hubmann W., Cohen R., Bender W., Haslacher C., Honicke S. Neurological soft signs in schizophrenia: assessment and correlates. European Archives of Psychiatry and Clinical Neuroscience 1996, 246:240-248.
35. Niethammer R., Weisbrod M., Schiesser S. Genetic influence on laterality in schizophrenia? A twin study of neurological soft signs. American Journal of Psychiatry 2000, 157:272-274.
36. Ovsiew F. Bedside neuropsychiatry: eliciting the clinical phenomena of neuropsychiatric illness. Synopsis of Neuropsychiatry 1994, 77-106. American Psychiatric Press, Washington, DC. S.C. Yudovsky, R.E. Hales (Eds.).
37. Prikryl R., Ceskova E., Kasparek T., Kucerova H. Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. Journal of Psychiatric Research 2006, 40:141-146.
38. Prikryl R., Ceskova E., Kasparek T., Kucerova H. Neurological soft signs and their relationship to 1-year outcome in first-episode schizophrenia. European Psychiatry 2007, 22:499-504.
39. Rubin P., Vostrup S., Hemmingsen R., Andersen H.S., Bendsen B.B. Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlation with computerized tomography and regional cerebral blood flow findings. Acta Psychiatrica Scandinavica 1994, 90:385-390.
40. Ruiz-Veguilla M., Cervilla J.A., Barrigon M.L., Ferrin M., Gutierrez B., Gordo E. Neurodevelopmental markers in different psychopathological dimensions of first episode psychosis: the ESPIGAS study. European Psychiatry 2008, 23:533-540.
41. Sanders R.D., Keshavan M.S., Schooler N.R. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. American Journal of Psychiatry 1994, 151:1231-1233.
42. Scheffer R.E. Abnormal neurological signs at the onset of psychosis. Schizophrenia Research 2004, 70:19-26.
43. Schröder J., Niethammer R., Geider F.J., Reitz C., Binkert M., Jauss M., Sauer H. Neurological soft signs in schizophrenia. Schizophrenia Research 1992, 6:25-30.
44. Schröder J., Silvestri S., Bubeck B. D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biological Psychiatry 1998, 43:660-665.
45. Schröder J., Heuser M. Neurological Soft Signs in first-episode schizophrenia. Directions in Psychiatry 2008, 28:227-243.
46. Smith R.C., Kadewari R.P., Rosenberger J.R., Bhattacharyya A. Nonresponding schizophrenia: differentiation by neurological soft signs and neuropsychological tests. Schizophrenia Bulletin 1999, 25:813-825.
47. Stoeber G., Ben-Shachar D., Cardon M., Falkai P., Fonteh A.N., Gawlik M., Glenthoj B., Grünblatt E., Jablensky A., Kim Y.K., Kornhuber J., McNeil T., Müller N., Oranje B., Saito T., Saoud M., Schmitt A., Schwartz M., Thome J., Uzbekov M., Durany N., Riederer P. Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. The World Journal of Biological Psychiatry 2009, 10:127-155.
48. Thomann P.A., Wüstenberg T., Santos V.D., Bachmann S., Essig M., Schröder J. Neurological soft signs and brain morphology in first-episode schizophrenia. Psychological Medicine 2008, 26:1-9.
49. Torrey E.F. Neurological abnormalities in schizophrenic patients. Biological Psychiatry 1980, 15:381-388.
50. Tosato S., Dazzan P. The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Current Opinion in Psychiatry 2005, 18:285-288.
51. Venkatasubramanian G., Latha V., Gangadhar B.N., Janakiramaiah N., Subbakrishna D.K., Jayakumar P.N. Neurological soft signs in never treated schizophrenia. Acta Psychiatrica Scandinavica 2003, 108:144-146.
52. Venkatasubramanian G., Jayakumar P.N., Gangadhar B.N., Keshavan M.S. Neuroanatomical correlates of neurological soft signs in antipsychotic naive schizophrenia. Psychiatry Research 2008, 164:215-222.
53. Whitty P., Clarke M., McTigue O., Browne S., Gerwin M., Kamali M. Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophrenia Research 2006, 86:110-117.
54. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 2003, 64:663-667.
55. Zabala A., Robles O., Parellada M., Moreno D.M., Ruiz-Sancho A., Burdalo M. Neurological soft signs in adolescents with first episode psychosis. European Psychiatry 2006, 21:283-287.